Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3 +CD16 -CD56 + natural killer T cells and CD4 +CD25 High regulatory T lymphocytes

Scandinavian Journal of Immunology

Volumn 62, Issue 3, 2005, Pages 297-308

  Vitelli Avelar, D M ^a,b   Sathler Avelar, R ^a,c   Dias, J C P ^a   Pascoal, V P M ^a   Teixeira Carvalho, A ^a,d   Lage, P S ^a   Eloi Santos S M ^a,c   Correa Oliveira R ^a,b   Martins Filho, O A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Instituto de Ciencias Biologicas   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EX VIVO STUDY; FEMALE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPHENOTYPING; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; B-LYMPHOCYTE SUBSETS; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; FEMALE; HLA-DR ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 26244455317     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01668.x     Document Type: Article

References (50)

1. Moncayo A. Progress towards the elimination of transmission of Chagas disease in Latin America. World Health Stat Q 1997;50:195-8.
2. WHO Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser 2002;905: i-vi, 1-109, back cover.
3. Brener Z, Gazzinelli RT. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997;114:103-10.
4. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3:253-7.
5. Piccirillo CA, Shevach EM. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 2004;16:81-8.
6. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
7. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
8. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3:33-4l.
9. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
10. Trzonkowski P, Szmit E, Mysliwska J, Dobyszuk A, Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004;112:258-67.
11. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-5.
12. Cassis L, Aiello S, Noris M. Natural versus adaptive regulatory T cells. Contrib Nephrol 2005;146:121-31.
13. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target Cell death. Immunity 2004;21:589-601.
14. + T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-40.
15. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-83.
16. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-68.
17. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004;114:1379-88.
18. Van der Vliet HJ, Molling JW, von Blomberg BM et al. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol 2004;112:8-23.
19. Matsuda JL, Gapin L, Baron JL et al. Mouse Vod4z natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci USA 2003;100:8395-400.
20. Vincent MS, Gumperz JE, Brenner MB. Understanding the function of CD1-restricted T cells. Nat Immunol 2003;4:517-23.
21. Hammond KJL, Kronenberg M. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol 2003;15:683-9.
22. + thymocytes. Int Immunol 1997;9:73-9.
23. + cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell Immunol 1991;136:486-95.
24. Kojo S, Tsutsumi A, Goto D, Sumida T. Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis. J Rheumatol 2003;30:2524-8.
25. Emoto M, Miyamoto M, Emoto Y et al. Highly biased type 1 immune responses in mice deficient in LFA-1 in Listeria monocytogenes infection are caused by elevated IL-12 production by granulocytes. J Immunol 2003;171:3970-6.
26. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao HR. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003;21:483-513.
27. Van Kaer L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res 2004;30:139-53.
28. Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun 2005;73:181-92.
29. Reis DD, Jones EM, Tostes S Jr. et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-α+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 1993;48:637-44.
30. Reis DD, Lemos ML, Silva GC et al. Phenotypic characterization of the inflammatory cells in chagasic mega-oesophagus. Trans R Soc Trop Med Hyg 2001;95:177-8.
31. Gaddy J, Broxmeyer HE. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997;180:132-42.
32. Sondergaard SR, Ullum H, Pedersen BK. Proliferative and cytotoxic capabilities of CD16+CD56- and CD16+/-CD56+ natural killer cells. APMIS 2000;108:831-7.
33. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 2001;167:1245-53.
34. Dutra WO, Martins-Filho OA, Cancado JR et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 1994;6:499-506.
35. Dutra WO, Martins-Filho OA, Cancado JR et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 1996;43:88-93.
36. Lemos EM, Reis D, Adad SJ, Silva GC, Crema E, Correa-Oliveira R. Decreased CD4(+) circulating T lymphocytes in patients with gastrointestinal Chagas disease. Clin Immunol Immunopathol 1998;88:150-5.
37. Higuchi Mde L, Gutierrez PS, Aiello VD et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993;423:157-60.
38. Corrêa-Oliveira R, Gomes J, Lemos EM et al. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 1999;94 (Suppl. 1):253-5.
39. Brener Z. Recent developments in the field of Chagas' disease. Bull World Health Organ 1982;60:463-73.
40. Golgher D, Gazzinelli RT. Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 2004;37:399-409.
41. Lanier LL, Phillips JHJ, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol 1986;137:2745-9.
42. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40.
43. Lieke T, Graefe SE, Klauenberg U, Fleischer B, Jacobs T. NK-cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect Immun 2004;72:6817-25.
44. Andrade ZA. Immunopathology of Chagas' disease. Mem Inst Oswaldo Cruz 1999;94:71-80.
45. Dittmer U, He H, Messer RJ et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004;20:293-303.
46. Erratum in: Immunity 2004: May; 20: 653.
47. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003;71:1185-93.
48. Norris S, Doherty DG, Collins C et al. Natural T cells in the human liver, cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Vαc24-JαQ and γδ receptor bearing cells. Hum Immunol 1999;60:20-31.
49. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-9.
50. int T cells in the liver of normal mice: implications for Ipr pathogenesis. Int Immunol 1994;6:533-40.